Author:
Rojo F.,Dalmases A.,Corominas J. M.,Albanell J.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference69 articles.
1. Mendelsohn J, Baselga J (2003) Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21:2787–2799
2. Baselga J, Albanell J (2002) Targeting epidermal growth factor receptor in lung cancer. Curr Oncol Rep 4:317–324
3. Albanell J, Rojo F, Baselga J (2001) Pharmacodynamic studies with the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839. Semin Oncol 28:56–66
4. Albanell J, Codony-Servat J, Rojo F et al (2001) Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res 61:6500–6510
5. Rojo F, Albanell J, Anido J et al (2002) Dose dependent pharmacodynamic effects of ZD1839 correlate with tumor growth inhibition in BT-474 breast cancer xenografts. Proc Am Assoc Cancer Res 43:705
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献